Overview
Prime contract obligationsObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary, FY2021–FY2025
1 of 2 registrations
Largest industry, FY2021–FY2025
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
Click a bar to open its page.
Insight Albert B. Sabin Vaccine Institute, Inc. (the) received 100%
Click a state to open its page.
- District of Columbia$572M · 100%
The latest fiscal year is reported so far (hatched)
Hover over a year to see its value.
Insight $70.4M in FY2025, 104% above FY2021
Largest company groups and registrations by prime obligations, FY2021–FY2025
Structure
Click a company to open its page.
Insight Albert B. Sabin Vaccine Institute, Inc. (the) holds 100%
Structure of Sabin Albert B Vaccine Inst: company groups and registrations by prime obligations, FY2021–FY2025
1 with a profile · 2 registrationsRegistration: a company's record for doing federal work. One company can hold several (one per location); we count registrations until they are merged. Glossary; open the 1 with a profile in the contractor directory (opens another page)
| Organization | Level | Location | Status | Prime obligations | Awards, all years |
|---|---|---|---|---|---|
| Sabin Albert B Vaccine Inst | Parent company | $265,266,288 | 6 | ||
| Albert B. Sabin Vaccine Institute, Inc. (the) (opens another page) | Registration | Washington, DC | Active | $265,266,288 | 3 |
| Sabin Albert B Vaccine InstNo profile yet | Registration | $0 | 3 |
Contracts
Contracts of Sabin Albert B Vaccine Inst's registrations, latest action first
Use this to find a contract of any registration in the family.
Showing 1–9 of 9 contracts
| Since award, US$ | |||||
|---|---|---|---|---|---|
| 75A50119C00055 | Albert B. Sabin Vaccine Institute, Inc. (the) | Office of Assistant Secretary for Preparedness and Response | $145,378,689 | Sep 18, 2026 | Sep 30, 2027 |
| 75A50126C00001 | Albert B. Sabin Vaccine Institute, Inc. (the) | Office of Assistant Secretary for Preparedness and Response | $263,613,186 | Aug 19, 2026 | Apr 30, 2036 |
| 75A50123C00010 | Albert B. Sabin Vaccine Institute, Inc. (the) | Office of Assistant Secretary for Preparedness and Response | $163,082,416 | May 11, 2026 | Sep 30, 2030 |
| 00100200204ASA020206PHP0001 | Sabin Albert B Vaccine Inst | Office of Assistant Secretary for Preparedness and Response | $25,000 | Apr 15, 2002 | Apr 15, 2002 |
| PHP0001 | Sabin Albert B Vaccine Inst | Office of Assistant Secretary for Preparedness and Response | $0 | Apr 15, 2002 | |
| 00100200202ASA020018ASP0603 | Sabin Albert B Vaccine Inst | Office of Assistant Secretary for Preparedness and Response | $25,000 | Feb 15, 2002 | Mar 15, 2002 |
| ASP0603 | Sabin Albert B Vaccine Inst | Office of Assistant Secretary for Preparedness and Response | $0 | Feb 15, 2002 | |
| 00100200111ASA020140035337 | Sabin Albert B Vaccine Inst | Office of Assistant Secretary for Preparedness and Response | $25,000 | Nov 15, 2001 | Jan 15, 2002 |
| 035337 | Sabin Albert B Vaccine Inst | Office of Assistant Secretary for Preparedness and Response | $0 | Nov 15, 2001 | |
Agencies
Click a bar to open its page.
Insight Office of Assistant Secretary for Preparedness and Response paid 100%
Sub-agencies by prime obligations to Sabin Albert B Vaccine Inst, FY2021–FY2025
Use this to see which sub-agencies pay the family's registrations; open one to see its offices.
1 sub-agencies paid the family
Showing 1–1 of 1 sub-agency
| FY2021–FY2025, US$ | FY2021–FY2025 | ||
|---|---|---|---|
| Office of Assistant Secretary for Preparedness and Response | Department of Health and Human Services | $265,266,288 | 8 |
Industries
Click a bar to open its page.
Insight 100% under Research and Development in Biotechnology (except Nanobiotechnology) (541714)
Industries by prime obligations, FY2021–FY2025
Use this to see what the family's registrations sell; open a code to see who else wins it.
Showing 1–1 of 1 industry code
| FY2021–FY2025, US$ | FY2021–FY2025 | |
|---|---|---|
| 541714 Research and Development in Biotechnology (except Nanobiotechnology) | $265,266,288 | 8 |
Places
Click a state to open its page.
- District of Columbia$572M · 100%
States of performance by prime obligations since award, contracts active FY2021 on
Use this to see where the family's contract work is performed; open a state to see its contractors.
Showing 1–1 of 1 state
| Contracts active since FY2021; since award, US$ | ||
|---|---|---|
| District of Columbia | $572,074,291 | 3 |